期刊文献+

深静脉血栓形成与凝血因子Ⅷ及蛋白C、蛋白S的相关性 被引量:19

Relationship between factor Ⅷ, protein C, protein S and lower deep venous thrombosis
原文传递
导出
摘要 目的检测下肢深静脉血栓形成的患者血浆中凝血因子Ⅷ(FⅧ)及蛋白C、蛋白s水平的变化,探讨其与深静脉血栓形成的关系。方法用ACLTOP型全自动血凝分析仪检测40例急性期深静脉血栓形成患者及40例健康体检者血浆中FⅧ及蛋白C、蛋白S的活性。结果与正常对照组比较,病例组患者体内FⅧ的活性明显增高,是深静脉血栓形成的危险因素,OR值为11.0,95%可信区间为3.3~36.7,排除蛋白C、蛋白S降低的影响,则OR值为5.4,95%可信区间为1.6~18.2。两组比较,病例组中蛋白C和蛋白S的活性明显降低,差异有统计学意义(P〈0.05)。结论深静脉血栓形成的患者体内FⅧ活性明显升高,而蛋白C及蛋白S的活性明显降低,凝血及抗凝系统的异常是深静脉廊栓形成的高危因素之一。 Objective To detect the activity of plasma factorⅧ, protein C, protein S in patients with lower deep venous thrombosis. Methods American IL automatic analyzer was used to detect the activity of factor Ⅷ, protein C and protein S in 40 patients with deep venous thrombosis and 40 normal controls. Results The plasma level of factor Ⅷ was statistically significantly higher in the study group than in the control group (P 〈 0. 05 ). Factor Ⅷ was associated with an increased risk of venous thrombosis with the relative risk being 11.0 (95% CI, 3.3-36. 7). Excluding the patients with reduced protein C and pro- tein S levels, the relative risk was dropped to 5.4 (95% CI, 1.6-18.2). There also were significant differences in the activity of protein C, protein S between the study group and the normal control group (P 〈 O. 05). Conclusion The activity of factor Ⅷ in patients with deep venous thrombosis is increased significantly, and the activity of protein C, protein S decreased obviously. All of those are risk factors for deep venous thrombosis.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2010年第5期575-576,共2页 Chinese Journal of Experimental Surgery
基金 上海市卫生局青年科研基金资助项目(2007Y30)
关键词 凝血因子Ⅷ 蛋白C 蛋白S 深静脉血栓形成 Factor Ⅷ Protein C Protein S Deep venous thrombosis
  • 相关文献

参考文献4

二级参考文献8

  • 1Ariens G,Alberio M,Moia PM,et al.Low levels of heparin-releasable tissue factor pathway inhibitor in young patients with thrombosis.J Thromb Haemost,1999,81:203-207.
  • 2Kleesik K,Schmidt M,Gotting C,et al.The 536C→T transition in the human tissue factor pathway inhibitor gene is statistically associated with a higher risk for venous thrombosis.J Thromb Haemost,1999,82:1-5.
  • 3Miyata T,Sakata T,Kumeda K,et al.C-399 polymorphism in the promoter region of human tissue factor pathway inhibitor gene does not change the plasma TFPI antigen level and does not cause venous thrombosis.J Thromb Haemost,1998,80:345-346.
  • 4Moatti D,Seknadji P,Galand C,et al.Polymorphisms of the human tissue factor pathway inhibitor gene in patients with acute coronary syndromes and in healthu subjects,impact of the V264M substitution on plasma levels of TFPI.Arterioscler Thromb Vasc Biol,1999,19:862-869.
  • 5Moatti D,Haidar B,Fumeron F,et al.A new T-287C polymorphism in the 5' regulatory region of the tissue factor pathway inhibitor gene.J Thromb Haemost,2000,84:244-249.
  • 6ShenL, DahlbackB.Factor V and Protein S as synergistic cdactors to activated protein C in degradation d factor Ⅷ a[J] .J Biolchem. 1994,269(29) : 18735.
  • 7Koppel man S J, Vant VemC, Six ma J J, et al. Synergistic inhibition of the intrinsic factor X activation by protein S and C4b binding protien[ J ]. Blood. 1995, 86(7) : 2653.
  • 8李德旭,杨镇,吴小勇,李海洋.细胞间粘附因子-1在门静脉高压患者脾静脉的表达及意义[J].中华实验外科杂志,2003,20(3):267-268. 被引量:5

共引文献9

同被引文献197

引证文献19

二级引证文献149

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部